YELESWARAM KRISHNASWAMY (Chief Development Officer) sold 7.6% of their position (20.23K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $808.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2026ACC: 0001193125-26-167091
Officer· Chief Development Officer
Since Feb 2026
-20.23K
Net shares
Net seller
$808.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
20.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20.23K
Price / share
$39.99
Trade value
$808.84K
% of position
7.6%
4/17/2026
266.65K→246.43K
Total
Net shares
−20.23K
Net value
-$808.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2026 | S · Sale | −20.23K | $39.99 | $808.84K | 7.6% | 266.65K | 246.43K |
| Total | −20.23K | -$808.84K | ||||||
Derivative Transactions0
No derivative transactions reported